| Net Cash Provided by (Used in) Financing Activities |
$9,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
8,000,000,000 |
shares |
|
Q2 2024 |
Q2 2024 |
| Common Stock, Shares, Issued |
3,313,405,751 |
shares |
|
Q2 2024 |
Q2 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,974 |
USD |
-4526% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Authorized |
2,000,000,000 |
shares |
|
Q2 2024 |
Q2 2024 |
| Additional Paid in Capital |
$903,664 |
USD |
|
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |